DIAMYD TO PRESENT PHASE II RESULTS FROM TYPE 1-DIABETES STUDY EARLIER THAN PLANNED

Press release: Stockholm – August 18, 2006 – Diamyd Medical AB (SWEDEN OMXS: DIAM B; USA ADR: DMYDY)

Diamyd Medical announces that the compilation of data from the Diamyd™ Phase II study in 70 children and adolescents with type 1-diabetes is advancing quicker than previsioned and that results from the study now are planned to be released on Tuesday, August 22nd after closure of the Stock Exchange.